Immunome
IMNM
IMNM
29 hedge funds and large institutions have $10.2M invested in Immunome in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
72% less capital invested
Capital invested by funds: $36.4M → $10.2M (-$26.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
29
Holding in Top 10
–
Calls
$240K
Puts
$163K
Top Buyers
| 1 | +$87K | |
| 2 | +$80K | |
| 3 | +$14.7K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$9.67K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.16K |
Top Sellers
| 1 | -$369K | |
| 2 | -$275K | |
| 3 | -$180K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$138K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$81K |